The United States currently uses two main pneumonia vaccines for adults: pneumococcal conjugate vaccines (PCV) and pneumococcal polysaccharide vaccines (PPSV23). These aren't interchangeable, and understanding the difference matters when thinking about timing recommendations.
Learn About Paying Your FGUA Bill Online →
PCV vaccines work by attaching pneumococcal proteins to a carrier substance, which helps your immune system recognize and remember the threat. The most commonly used PCV for adults is PCV20 (Pneumovax 20), approved by the FDA in 2021, which protects against 20 strains of pneumococcus bacteria. Before PCV20, adults typically received PCV13 (Pneumovax 13), which covers 13 strains. PPSV23 (Pneumovax 23) covers 23 strains but works differently—it's a polysaccharide vaccine that directly triggers immune response without a carrier protein.
Why the distinction matters: Your immune system responds more robustly to conjugate vaccines, which is why they're considered "stronger" for certain populations. However, PPSV23 covers additional strains that PCV20 doesn't include. This is why the CDC's current recommendations often involve receiving both vaccines—they work together to cover more bacterial strains.
The timing between these vaccines is critical. If you receive them in the wrong order or too close together, your immune system may not develop optimal protection. For instance, PPSV23 given too soon after PCV can actually reduce the immune response to the PPSV23. This is why spacing recommendations exist—they're based on how your body's immune system works, not arbitrary numbers.
Practical takeaway: Before looking at timing, confirm which vaccines you've already received. Your vaccination record should specify PCV13, PCV20, and any PPSV23 doses. This information is the foundation for determining what timing recommendations apply to you.
The CDC updated pneumonia vaccine recommendations in October 2023, shifting the approach from previous years. The new framework emphasizes that adults 19 and older with certain health conditions or risk factors should follow specific sequences, and timing depends on whether you've been vaccinated before and what you've received.
Free Guide to Pay by Plate Illinois Billing →
For adults aged 65 and older with no previous pneumococcal vaccination history, the recommended sequence is: receive one dose of PCV20, followed by PPSV23 at least 12 months later (though it can be given as soon as 1 year after PCV20). This provides protection against both the strains covered by each vaccine.
For adults aged 19-64 with chronic conditions like heart disease, diabetes, or chronic lung disease, or those who smoke, the sequence typically involves PCV20 followed by PPSV23 after at least 12 months. However, if someone previously received PPSV23, the timing changes—they would receive PCV20 at least 12 months after the PPSV23.
The timing recommendations specifically address the immune response issue mentioned earlier. The 12-month spacing allows your immune system to fully respond to the first vaccine and "reset" before the second vaccine. Some older recommendations used shorter intervals, but research showed that longer spacing produces better immune memory.
Adults who previously received PCV13 follow a different path. If you got PCV13 years ago, the current recommendation is to follow it with PCV20, but not sooner than 12 months after PCV13. If PPSV23 was given after your PCV13, you'd then receive PCV20 at least 1 year after PPSV23.
Practical takeaway: Write down the exact dates of any pneumococcal vaccines you've received and which type (PCV13, PCV20, or PPSV23). Bring this information to your doctor's appointment—it's the quickest way to determine your personalized timing.
Pneumonia vaccine recommendations differ significantly by age group, reflecting changes in immune function and health risk over time. Understanding age-based guidelines helps explain why your neighbor's timing might not match yours.
Free Guide to Mold Removal Methods for Walls →
For adults aged 19-64, recommendations vary based on health status. If you're generally healthy with no chronic conditions and you don't smoke, you typically don't need pneumonia vaccines at this age. However, if you have asthma, COPD, heart disease, diabetes, a weakened immune system, or if you're a current smoker, you should discuss pneumonia vaccination with your doctor. The timing for this group often involves starting with PCV20 if you've had no prior pneumococcal vaccination.
The recommendations shift at age 65. Everyone aged 65 and older should receive pneumonia vaccination regardless of previous health status. For someone who's never been vaccinated, one dose of PCV20 followed by PPSV23 after at least 12 months provides the recommended protection. This age-based shift reflects that pneumonia risk increases significantly after 65—studies show hospitalization rates for pneumococcal pneumonia increase dramatically in this age group.
For adults who reach 65 having previously received PPSV23 or PCV13 when younger, the sequence changes. If PPSV23 was given before age 65, they'd receive PCV20 at least 12 months after that PPSV23. These timing rules prevent overly frequent vaccination, which doesn't improve protection and may increase side effects.
Special cases include adults with severely weakened immune systems (such as those with HIV or undergoing chemotherapy). These individuals typically follow accelerated timelines with shorter spacing between doses—sometimes as little as 4 weeks—because their immune systems need more exposure to develop protection.
Practical takeaway: Your age and current health status are the primary factors determining your pneumonia vaccine timing. If you're approaching 65 or have a chronic health condition, this is a conversation worth initiating with your primary care doctor now, rather than waiting.
Certain health conditions change pneumonia vaccine timing recommendations because they increase both the risk of pneumococcal disease and the need for protection. These include chronic lung diseases, heart conditions, diabetes, liver disease, kidney disease, and conditions affecting the immune system.
How to Delete Your Fitbit Account Guide →
Adults with chronic obstructive pulmonary disease (COPD) or asthma face higher pneumonia risk because the lung damage or inflammation already present makes bacterial infection more likely to become severe. For this group, pneumonia vaccination is recommended regardless of age, and timing typically follows the standard PCV20 followed by PPSV23 sequence if no prior vaccination exists. If someone with COPD previously received PPSV23 and is now seeking to update their protection, they'd receive PCV20 at least 12 months after that prior PPSV23.
People with diabetes have increased susceptibility to severe pneumococcal infections due to changes in how their immune system functions. The timing recommendations for adults with diabetes align with those for other chronic conditions: PCV20 followed by PPSV23 after at least 12 months if starting fresh, or PCV20 after 12 months following any prior PPSV23.
Those with weakened immune systems—including people with HIV, those taking immunosuppressive medications for autoimmune conditions, or people undergoing cancer treatment—follow different timing. These individuals often need protection sooner and may receive vaccines on a compressed schedule. For example, some may receive PPSV23 as soon as 4 weeks after PCV20 rather than waiting 12 months. This compressed timing reflects the higher urgency of protection in this population.
Asplenia (removal of the spleen) or functional asplenia (spleen not working properly, as occurs in sickle cell disease) also triggers specific timing. The spleen plays a major role in fighting pneumococcal infection, so people without a working spleen need vaccination before or shortly after the condition develops. Timing might involve receiving both vaccines sooner than the standard 12-month interval.
Practical takeaway: If you have any chronic condition affecting your lungs, heart, kidneys, metabolism, or immune system, mention pneumonia vaccination to your doctor at your
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.